HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheung, A. T. Articles by Stenach, N. Search for Related Content PubMed PubMed Citation Articles by Cheung, A. T. Articles by Stenach, N.

The Annals of Thoracic Surgery, Vol 58, 541-542, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations

AT Cheung, SK Levin, SJ Weiss, MA Acker and N Stenach
Department of Anesthesia, University of Pennsylvania, Philadelphia 19104-4293.

Mitral valve replacement was performed urgently in a patient with hemorrhagic brain lesions. To decrease the risk of intracranial hemorrhage, cardiopulmonary bypass was performed using a heparin-coated perfusion system and a reduced dose of heparin. The detection of an acute intracardiac thrombus by transesophageal echocardiography during cardiopulmonary bypass exposed a potential hazard of techniques employing reduced systemic anticoagulation for cardiac operations.

This article has been cited by other articles:

				J. S. Savino and A. T. Cheung Cardiac Anesthesia Card. Surg. Adult, January 1, 2008; 3(2008): 281 - 314. [Full Text]

				C. W. Hogue and M. J. London Aprotinin's Effect on ACT is Not an Artifact Anesth. Analg., May 1, 2007; 104(5): 1302 - 1303. [Full Text] [PDF]

				S. T. Morozowich, B. S. Donahue, and I. J. Welsby Genetics of coagulation: considerations for cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 297 - 313. [Abstract] [PDF]

				G. Despotis, M. Avidan, and D. M. Lublin Off-Label Use of Recombinant Factor VIIA Concentrates After Cardiac Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 3 - 5. [Full Text] [PDF]

				M.S. Avidan, J.H. Levy, H. van Aken, R.O. Feneck, R.D. Latimer, E. Ott, E. Martin, D.E. Birnbaum, L.J. Bonfiglio, D.K. Kajdasz, et al. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 107 - 113. [Abstract] [Full Text] [PDF]

				G. M. Palatianos, C. N. Foroulis, M. I. Vassili, G. Astras, K. Triantafillou, E. Papadakis, A. A. Lidoriki, E. Iliopoulou, and E. N. Melissari A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit Ann. Thorac. Surg., July 1, 2003; 76(1): 129 - 135. [Abstract] [Full Text] [PDF]

				J. S. Savino, T. F. Floyd, and A. T. Cheung Cardiac Anesthesia Card. Surg. Adult, January 1, 2003; 2(2003): 249 - 281. [Full Text]

				M. G. Licina, R. M. Savage, C. Hearn, and E. J. Kraenzler The Role of Transesophageal Echocardiography in Perfusion Management Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 321 - 334. [Abstract] [PDF]

				G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831. [Abstract] [Full Text] [PDF]

				M. Codispoti, C. A. Ludlam, D. Simpson, and P. S. Mankad Individualized heparin and protamine management in infants and children undergoing cardiac operations Ann. Thorac. Surg., March 1, 2001; 71(3): 922 - 927. [Abstract] [Full Text] [PDF]

				A. M. Lincoff, L. A. LeNarz, G. J. Despotis, P. K. Smith, J. E. Booth, R. E. Raymond, S. K. Sapp, C. F. Cabot, J. E. Tcheng, R. M. Califf, et al. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials Ann. Thorac. Surg., August 1, 2000; 70(2): 516 - 526. [Abstract] [Full Text] [PDF]

				M. Codispoti and P. S Mankad Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice Perfusion, May 1, 2000; 15(3): 191 - 201. [Abstract] [PDF]

				F. D. Rubens, R. S. Labow, G. R. Lavallee, M. I. Watson, J. A. Robblee, M. E. Voorhees, and H. J. Nathan Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer Ann. Thorac. Surg., March 1, 1999; 67(3): 689 - 696. [Abstract] [Full Text] [PDF]

				A. H. Kuitunen, L. J. Heikkila, and M. T. Salmenpera Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation Ann. Thorac. Surg., February 1, 1997; 63(2): 438 - 444. [Abstract] [Full Text]

				D. D. Muehrcke, P. M. McCarthy, K. Kottke-Marchant, H. Harasaki, J. Pierre-Yared, J. A. Borsh, D. A. Ogella, and D. M. Cosgrove BIOCOMPATIBILITY OF HEPARIN-COATED EXTRACORPOREAL BYPASS CIRCUITS: A RANDOMIZED, MASKED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 472 - 483. [Abstract] [Full Text]

				R. C. Gorman, N. P. Ziats, A. K. Rao, N. Gikakis, L. Sun, M. M. H. Khan, N. Stenach, S. Sapatnekar, V. Chouhan, J. H. Gorman III, et al. SURFACE-BOUND HEPARIN FAILS TO REDUCE THROMBIN FORMATION DURING CLINICAL CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 1 - 12. [Abstract] [Full Text]

				D. D. Muehrcke, P. M. McCarthy, R. W. Stewart, S. Seshagiri, D. A. Ogella, R. C. Foster, and D. M. Cosgrove Complications of extracorporeal life support systems using heparin-bound surfaces: The risk of intracardiac clot formation J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 843 - 851. [Abstract] [Full Text]